These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3015624)

  • 1. Possible polyclonal B cell activation in mucocutaneous lymph node syndrome.
    Furukawa F; Ohshio G; Hamashima Y
    Eur J Pediatr; 1986 Apr; 145(1-2):104-8. PubMed ID: 3015624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome.
    Leung DY; Chu ET; Wood N; Grady S; Meade R; Geha RS
    J Immunol; 1983 May; 130(5):2002-4. PubMed ID: 6220072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease).
    Lin CY; Hwang B
    Ann Allergy; 1987 Oct; 59(4):291-7. PubMed ID: 3662131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro Lymphocyte response to mite antigen in Kawasaki disease (MCLS)].
    Hirota T; Kimoto K; Furusho K
    Arerugi; 1982 Oct; 31(10):1070-3. PubMed ID: 7168650
    [No Abstract]   [Full Text] [Related]  

  • 5. Human herpesvirus 6 infection and Kawasaki disease.
    Okano M; Luka J; Thiele GM; Sakiyama Y; Matsumoto S; Purtilo DT
    J Clin Microbiol; 1989 Oct; 27(10):2379-80. PubMed ID: 2555393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune complex study of biopsy specimens from Kawasaki disease patients.
    Fujimoto T; Kato H; Inoue O; Tomita S; Koga Y
    Prog Clin Biol Res; 1987; 250():209-17. PubMed ID: 3321077
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of immunoglobulin on immune complexes in patients with Kawasaki disease (MCLS).
    Koike R
    Acta Paediatr Jpn; 1991 Jun; 33(3):300-9. PubMed ID: 1785324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytopathogenic protein (CPP) produced by Propionibacterium acnes isolated from patients with Kawasaki disease.
    Tomita S; Koga Y; Inoue O; Fujimoto T; Kato H
    Prog Clin Biol Res; 1987; 250():73-80. PubMed ID: 3423083
    [No Abstract]   [Full Text] [Related]  

  • 9. Antineutrophil cytoplasm antibodies in Kawasaki disease.
    Savage CO; Tizard J; Jayne D; Lockwood CM; Dillon MJ
    Arch Dis Child; 1989 Mar; 64(3):360-3. PubMed ID: 2650637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyclonal B cell activation and autoimmunity in New Zealand mice. I. Natural thymocytotoxic autoantibody (NTA).
    Hirose S; Maruyama N; Ohta K; Shirai T
    J Immunol; 1980 Aug; 125(2):610-5. PubMed ID: 6967083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperreactivity of lymphocytes to streptolysin O and lack of plasma inhibitory factor (s) in patients with mucocutaneous lymphnode syndrome.
    Wakiguchi H; Fujieda M; Matsumoto K; Ohara Y; Wakiguchi A; Shiraishi T; Kurashige T; Kitamura I
    Acta Med Okayama; 1986 Dec; 40(6):285-9. PubMed ID: 3825591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some factors of immunopathogenesis of infectious mononucleosis in children.
    Rudkowski Z; Kacprzak-Bergman I; Jankowski A; Krawczyk K
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):101-4. PubMed ID: 6293402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of antibodies to human parvovirus in erythema infectiosum (fifth disease).
    Okabe N; Koboyashi S; Tatsuzawa O; Mortimer PP
    Arch Dis Child; 1984 Nov; 59(11):1016-9. PubMed ID: 6095770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of Kawasaki disease and the initial infection by EB virus].
    Kikuta H; Mizuno F; Osato T; Konno M; Ishikawa N; Nanbu H; Anakura M; Oka Y; Matsumoto S; Noro S
    Nihon Rinsho; 1983 Sep; 41(9):2069-74. PubMed ID: 6319775
    [No Abstract]   [Full Text] [Related]  

  • 15. Epstein-Barr virus-specific cytotoxic T lymphocyte (EBV-CTL) activities in patients with Kawasaki syndrome.
    Shinohara K; Katsuki T; Koike M
    Prog Clin Biol Res; 1987; 250():569-70. PubMed ID: 2827182
    [No Abstract]   [Full Text] [Related]  

  • 16. The enhancement of anti-myosin antibody in mucocutaneous lymph node syndrome.
    Arimura A; Shimbo T
    Prog Clin Biol Res; 1987; 250():539-40. PubMed ID: 3423066
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating immune complex in the mucocutaneous lymph node syndrome.
    Furuse A; Matsuda I
    Eur J Pediatr; 1983 Oct; 141(1):50-1. PubMed ID: 6641766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of measles virus from child with Kawasaki disease.
    Whitby D; Hoad JG; Tizard EJ; Dillon MJ; Weber JN; Weiss RA; Schulz TF
    Lancet; 1991 Nov; 338(8776):1215. PubMed ID: 1682629
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of B cell immunity to DNP by serotherapy with monoclonal anti-DNP antibodies. Effect of the treatment schedule on the magnitude of specific suppression and its duration.
    Beining PR; Merchant B; Lizzio EF; Hoffman T
    Transplantation; 1986 Nov; 42(5):524-8. PubMed ID: 3491449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aetiology of Kawasaki disease.
    Bannister BA; Edwards S; Ibata G
    Arch Dis Child; 1989 Mar; 64(3):397-8. PubMed ID: 2539788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.